Nordwand Advisors, LLC Novo Cure LTD Transaction History
Nordwand Advisors, LLC
- $374 Billion
- Q3 2024
A detailed history of Nordwand Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Nordwand Advisors, LLC holds 3,029,824 shares of NVCR stock, worth $97.3 Million. This represents 12.67% of its overall portfolio holdings.
Number of Shares
3,029,824
Previous 1,515,000
99.99%
Holding current value
$97.3 Million
Previous $26 Billion
82.48%
% of portfolio
12.67%
Previous 11.32%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$389 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$380 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$254 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$138 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$90.1 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.37B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...